Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,308 public trials 520 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Recruiting

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

NCT06769698

Conditions
Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +12 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Orlando Health Orlando, Florida, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
  • St. Elizabeth Healthcare Edgewood, Kentucky, United States
View all 27 locations
View Trial Details
Recruiting

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

NCT03970447

Conditions
Astrocytoma, Disease Attributes, Glioblastoma, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California, San Diego La Jolla, California, United States
  • Cedars Sinai - Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • University of California, Los Angeles Los Angeles, California, United States
View all 63 locations
View Trial Details
Recruiting

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

NCT07424833

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +33 more
Locations
  • Mayo Clinic Jacksonville, Florida, United States
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • START Los Angele Los Angeles, California, United States
  • START Midwest Grand Rapids, Michigan, United States
View Trial Details
Recruiting

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

NCT07586618

Conditions
Acute Lymphoblastic Leukemia ALL, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Cook Children's Medical Center Fort Worth, Texas, United States
  • Texas Children's Hospital Houston, Texas, United States
View Trial Details
Recruiting

A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma

NCT07116616

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • University of Alabama at Birmingham Hospital Birmingham, Alabama, United States
  • UCSF San Francisco, California, United States
  • Emory University Hospital Atlanta, Georgia, United States
  • Mass General Brigham Boston, Massachusetts, United States
View Trial Details

Related conditions